iSERA Lifesciences Limited (Formerly known as Covidh Technologies Limited)has filed with exchange monitoring agency report for quarter ended March 31, 2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
iSERA Lifesciences (formerly Covidh Technologies) submitted its quarterly monitoring agency report to BSE for the quarter ending March 31, 2026. The report, issued by Infomerics Valuation and Rating Limited, covers the utilization of Rs. 8.08 crore raised through a Rights Issue. The monitoring agency has confirmed nil deviation from the objects stated in the issue document, meaning the company deployed the funds as committed to investors. This is a mandatory compliance filing under SEBI regulations for companies that have raised capital through rights issues. The filing was submitted on May 15, 2026.
Positive signal for shareholders as the independent monitoring agency confirms the rights issue proceeds were used as promised with zero deviation. This reduces concerns about fund mismanagement and maintains transparency in capital deployment.